People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Active, not recruiting · NCT03520660 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Fibrosis, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, adenocarcinoma, carcinoma, cardiovascular disorder, chronic hepatitis C virus infection, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatitis, hepatitis C virus infection, hepatocellular carcinoma, infectious disease, liver disorder, metabolic disease, neoplasm, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2026-10-02 | NCT03520660 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |